Usaf Sz-B en es it fr

Usaf Sz-B Brand names, Usaf Sz-B Analogs

Usaf Sz-B Brand Names Mixture

  • No information avaliable

Usaf Sz-B Chemical_Formula


Usaf Sz-B RX_link

Usaf Sz-B fda sheet

Usaf Sz-B msds (material safety sheet)

Usaf_Sz-B MSDS

Usaf Sz-B Synthesis Reference

Bourquin et al., Helv. Chim. Acta 41, 1072 (1958)

Usaf Sz-B Molecular Weight

370.577 g/mol

Usaf Sz-B Melting Point

73 oC

Usaf Sz-B H2O Solubility

0.0336 mg/L

Usaf Sz-B State


Usaf Sz-B LogP


Usaf Sz-B Dosage Forms

Suspension; Tablet

Usaf Sz-B Indication

For the treatment of schizophrenia and generalized anxiety disorder.

Usaf Sz-B Pharmacology

Thioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.

Usaf Sz-B Absorption


Usaf Sz-B side effects and Toxicity

LD50=956-1034 mg/kg (Orally in rats); Agitation, blurred vision, coma, confusion, constipation, difficulty breathing, dilated or constricted pupils, diminished flow of urine, dry mouth, dry skin, excessively high or low body temperature, extremely low blood pressure, fluid in the lungs, heart abnormalities, inability to urinate, intestinal blockage, nasal congestion, restlessness, sedation, seizures, shock

Usaf Sz-B Patient Information

Usaf Sz-B Organisms Affected

Humans and other mammals